Fund Overview of Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth
-
₹28.4 CrAUM
-
₹10.59NAV
-
1.11%Expense Ratio
-
EquityFund Category
Returns of Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.45% | NA | 6.12% |
| 6 Months | 13.78% | NA | 12.92% |
Asset Allocation
equities
99.88%other assets or cash equivalents
0.12%Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth is one Equity mutual fund offered by Motilal Oswal Mutual Fund. Launched on 19 Nov 2024, the fund aims Return that corresponds to the returns of the Nifty MidSmall Healthcare Total Return Index, subject to tracking error. Long term capital growth. It manages assets worth ₹28.4 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹9.00 and ₹11.08. The expense ratio stands at 1.11%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth
The portfolio allocation consists of 99.88% in equities, 0.12% in other assets or cash equivalents. Managed by Rakesh Shetty, it has delivered a return of 0.00% in the last year, a total return since inception of 7.12%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from Motilal Oswal Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Motilal Oswal Bse Healthcare Etf - Growth
|
₹32 | -0.56% | 0.12% | 4.85% | 5.63% | 24.39% |
|
Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
|
₹28 | -0.89% | -2.15% | 5.62% | - | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Max Healthcare Institute Ltd | Healthcare | 15.07% | ₹4.28 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.91% | ₹2.93 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.91% | ₹2.93 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.59% | ₹2.79 Cr |
| Lupin Ltd | Healthcare | 8.83% | ₹2.61 Cr |
| Lupin Ltd | Healthcare | 8.83% | ₹2.61 Cr |
| Lupin Ltd | Healthcare | 8.77% | ₹2.56 Cr |
| Lupin Ltd | Healthcare | 7.59% | ₹2.15 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.27% | ₹2.06 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹2.04 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹2.04 Cr |
| Laurus Labs Ltd | Healthcare | 6.20% | ₹1.81 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹1.75 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹1.75 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹1.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹1.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.80% | ₹1.69 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.75% | ₹1.68 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.58% | ₹1.63 Cr |
| Laurus Labs Ltd | Healthcare | 5.57% | ₹1.58 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.29% | ₹1.56 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.29% | ₹1.56 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.22% | ₹1.52 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.22% | ₹1.48 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.01% | ₹1.48 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.01% | ₹1.48 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.19% | ₹1.47 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.71% | ₹1.34 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.39% | ₹1.25 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹1.23 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹1.23 Cr |
| Biocon Ltd | Healthcare | 3.89% | ₹1.13 Cr |
| Biocon Ltd | Healthcare | 3.82% | ₹1.08 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.53% | ₹1.03 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹0.98 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹0.98 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹0.97 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹0.97 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.27% | ₹0.95 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.33% | ₹0.95 Cr |
| Gland Pharma Ltd | Healthcare | 3.01% | ₹0.88 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.00% | ₹0.85 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Abbott India Ltd | Healthcare | 2.90% | ₹0.84 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Abbott India Ltd | Healthcare | 2.80% | ₹0.83 Cr |
| Abbott India Ltd | Healthcare | 2.80% | ₹0.83 Cr |
| Abbott India Ltd | Healthcare | 2.80% | ₹0.79 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.69% | ₹0.78 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.62% | ₹0.77 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.62% | ₹0.77 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.64% | ₹0.77 Cr |
| Gland Pharma Ltd | Healthcare | 2.67% | ₹0.76 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹0.75 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹0.75 Cr |
| Wockhardt Ltd | Healthcare | 2.38% | ₹0.69 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.37% | ₹0.69 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹0.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹0.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.29% | ₹0.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.29% | ₹0.68 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.33% | ₹0.66 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹0.66 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹0.66 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.26% | ₹0.66 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.22% | ₹0.66 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.22% | ₹0.66 Cr |
| Syngene International Ltd | Healthcare | 2.24% | ₹0.65 Cr |
| Piramal Pharma Ltd | Healthcare | 2.24% | ₹0.65 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.24% | ₹0.65 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.21% | ₹0.63 Cr |
| Syngene International Ltd | Healthcare | 2.20% | ₹0.63 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.13% | ₹0.62 Cr |
| Global Health Ltd | Healthcare | 2.10% | ₹0.61 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹0.61 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹0.61 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.09% | ₹0.61 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.12% | ₹0.60 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.11% | ₹0.60 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.01% | ₹0.59 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.01% | ₹0.59 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.07% | ₹0.59 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹0.58 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹0.58 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.93% | ₹0.57 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.93% | ₹0.57 Cr |
| Piramal Pharma Ltd | Healthcare | 1.98% | ₹0.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.93% | ₹0.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.90% | ₹0.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.90% | ₹0.56 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.92% | ₹0.56 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.91% | ₹0.54 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.88% | ₹0.53 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹0.53 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹0.53 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.80% | ₹0.51 Cr |
| Global Health Ltd | Healthcare | 1.79% | ₹0.51 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹0.45 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹0.45 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹0.43 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹0.43 Cr |
| Pfizer Ltd | Healthcare | 1.45% | ₹0.42 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹0.42 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹0.42 Cr |
| Granules India Ltd | Healthcare | 1.42% | ₹0.41 Cr |
| Poly Medicure Ltd | Healthcare | 1.41% | ₹0.41 Cr |
| Natco Pharma Ltd | Healthcare | 1.36% | ₹0.40 Cr |
| Natco Pharma Ltd | Healthcare | 1.36% | ₹0.40 Cr |
| Natco Pharma Ltd | Healthcare | 1.39% | ₹0.39 Cr |
| Natco Pharma Ltd | Healthcare | 1.35% | ₹0.39 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹0.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹0.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.29% | ₹0.37 Cr |
| Pfizer Ltd | Healthcare | 1.27% | ₹0.36 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.23% | ₹0.35 Cr |
| Poly Medicure Ltd | Healthcare | 1.20% | ₹0.34 Cr |
| Granules India Ltd | Healthcare | 1.12% | ₹0.32 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.89% | ₹0.25 Cr |
| Net Receivables | Unspecified | 0.34% | ₹0.10 Cr |
| Net Receivables | Unspecified | 0.12% | ₹0.04 Cr |
| Net Receivables | Unspecified | 0.12% | ₹0.04 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.03 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth
What is the current AUM of Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth?
As of Thu Jul 31, 2025, Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth manages assets worth ₹28.4 crore
How has Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth performed recently?
- 3 Months: 1.45%
- 6 Months: 13.78%
What is the long-term performance of Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth?
- Since Inception: 7.12%
What is the portfolio composition of Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth?
Equity: 99.88%, Others: 0.12%.
Who manages Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth?
Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth is managed by Rakesh Shetty from Motilal Oswal Mutual Fund.
What is the market-cap allocation of Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth?
Large Cap: 13.85%, Mid Cap: 52.37%, Small Cap: 33.78%.
Which are the top companies Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth has invested in?
- Max Healthcare Institute Ltd – 15.07% of the fund's portfolio
- Fortis Healthcare Ltd – 9.91% of the fund's portfolio
- Fortis Healthcare Ltd – 9.91% of the fund's portfolio
- Fortis Healthcare Ltd – 9.59% of the fund's portfolio
- Lupin Ltd – 8.83% of the fund's portfolio
Which are the major sectors Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth focuses on?
- Healthcare – 399.54% of the fund's portfolio
- Unspecified – 0.46% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


